Form 483

Otsuka Pharmaceutical Co., Ltd. Form 483, 2019-02-15

FDA issued a Form 483 to Otsuka Pharmaceutical Co., Ltd. on 2019-02-15 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Otsuka Pharmaceutical Co., Ltd. · Itano-Gun, Japan · Issued February 15, 2019

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

15 Feb 2019
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Jose A Cruz Gonzalez

15 Feb 2019
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Jose A Cruz Gonzalez

15 Feb 2019
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Jose A Cruz Gonzalez

15 Feb 2019
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Jose A Cruz Gonzalez

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere